Protocol Page


	Study ID (Protocol Number)
	AI452-020


	STUDY LOCATIONS*
	Anaheim Clinical Trials Llc Anaheim, CA 92801 Recruiting	Gastrointestinal Specialists Of Georgia Pc Marietta, GA 30060 Recruiting
	Gastro One Germantown, TN 38138 Recruiting	Healthcare Research Consultants Tulsa, OK 74135 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir
	STUDY OVERVIEW
	The purpose of this study is to determine whether Peginterferon Lambda-1a (Lambda) combined with Ribavirin (RBV) and Telaprevir (TVR) is effective in the treatment of chronic Hepatitis C (CHC) compared to Peginterferon Alfa-2a (alfa-2a) combined with RBV and Telapravir.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.